Jeddah: Julphar (Gulf Pharmaceutical Industries) has signed a long-term lease agreement with Modon 3rd Industrial City in Jeddah to establish an integrated pharmaceutical manufacturing facility in Saudi Arabia. This move aims to localize pharmaceutical manufacturing, strengthen national health security, and create a hub for exporting pharmaceutical products to GCC countries and global markets.
According to Emirates News Agency, the project aligns with Saudi Vision 2030 by focusing on technology transfer, developing local industrial capabilities, and enhancing self-sufficiency in the pharmaceutical sector. The initiative represents a total investment of approximately SAR 300 million and will be developed on a 45,000 square metre land area. The facility is expected to generate up to 1,400 direct employment opportunities, thus supporting economic growth and social development.
The manufacturing site is strategically located within one of the Kingdom's key industrial zones to ensure efficient supply chains and seamless access to local and regional markets. The facility is also designed to serve as a pharmaceutical export platform for the US and other international markets, forming part of a globally accredited manufacturing network with a proven track record in exporting to over 40 countries.
Julphar plans to implement advanced manufacturing technologies, including sterile injectables and oral solid dosage forms, in compliance with international quality, safety, and regulatory standards. The product portfolio will focus on biologics and specialty pharmaceuticals for critical care and chronic disease areas, with plans to expand in line with the evolving needs of the Saudi and regional markets.
Sheikh Saqr bin Humaid Al Qasimi, Chairman of Julphar, stated that the establishment of the facility in Saudi Arabia is a strategic milestone in their expansion journey, reflecting a commitment to regional health security and local pharmaceutical manufacturing. Dr. Basel Ziyadeh, CEO of Julphar, added that the project represents a long-term strategic investment that will strengthen Julphar's position as a leading pharmaceutical hub in the MENA region and emphasized their commitment to quality standards and developing local talent.